Professor Eva Segelov

Honorary Associate
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone 02 83822352
Fax 02 83822794

Map

Selected grants

2018

  • Personalisation of Aspirin Adjuvant Therapy in Patients with Colorectal Cancer; Sieber O, Simes R, Segelov E, Segelov E, Sieber O; National Health and Medical Research Council (NHMRC)/Project Grants.

2014

  • ASCOLT: Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers. An International, Multi-centre, Double Blind, Randomised Trial; Segelov E, Simes R, Tebbutt N, Zalcberg J, Sommeijer D, Chia J; Cancer Australia/Priority Driven Collaborative Cancer Research Scheme.

2012

  • Merck Serono Australia; Segelov E; Merck Serono Australia Pty Ltd/Research Support.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Tang, M., Price, T., Shapiro, J., Gibbs, P., Haller, D., Arnold, D., Peeters, M., Segelov, E., Roy, A., Tebbutt, N., Pavlakis, N., et al (2018). Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis. Expert Review of Anticancer Therapy, 18(4), 339-349. [More Information]
  • Shapiro, J., Thavaneswaran, S., Underhill, C., Robledo, K., Karapetis, C., Day, F., Nott, L., Jefford, M., Chantrill, L., Pavlakis, N., Khasraw, M., Simes, R., Gebski, V., et al (2018). Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. Clinical Colorectal Cancer, 17(4), 313-319. [More Information]
  • Chan, D., Moody, L., Segelov, E., Metz, D., Strosberg, J., Pavlakis, N., Singh, S. (2018). Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS). Neuroendocrinology, 107(1), 32-41. [More Information]
  • Singh, S., Moody, L., Chan, D., Metz, D., Strosberg, J., Asmis, T., Bailey, D., Bergsland, E., Pavlakis, N., Segelov, E., et al (2018). Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors. JAMA Oncology, 4(11), 1597-1604. [More Information]
  • Price, T., Tang, M., Gibbs, P., Haller, D., Peeters, M., Arnold, D., Segelov, E., Roy, A., Tebbutt, N., Pavlakis, N., et al (2018). Targeted therapy for metastatic colorectal cancer. Expert Review of Anticancer Therapy, 18(10), 991-1006. [More Information]
  • Sandler, C., Goldstein, D., Horsfield, S., Bennett, B., Friedlander, M., Bastick, P., Lewis, C., Segelov, E., Boyle, F., Chin, M., et al (2017). Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue. Journal of Pain and Symptom Management, 54(1), 74-84. [More Information]
  • Soon, S., Chia, J., Chan, M., Ho, G., Jian, X., Deng, Y., Tan, C., Segelov, E., Mehta, S., Ali, R., et al (2014). Cost-Effectiveness of Aspirin Adjuvant Therapy in Early Stage Colorectal Cancer in Older Patients. PloS One, 9(9), 1-14. [More Information]
  • Price, T., Shapiro, J., Segelov, E., Karapetis, C., Pavlakis, N., Van Cutsem, E., Shah, M., Kang, Y., Tebbutt, N. (2012). Management of advanced gastric cancer. Expert Review of Gastroenterology and Hepatology, 6(2), 199-209. [More Information]
  • Tebbutt, N., Karapetis, C., Segelov, E., Pavlakis, N., Cunningham, D., Sobrero, A., Haller, D., Shapiro, J. (2010). Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008. Clinical Colorectal Cancer, 9(1), 8-14. [More Information]

2018

  • Tang, M., Price, T., Shapiro, J., Gibbs, P., Haller, D., Arnold, D., Peeters, M., Segelov, E., Roy, A., Tebbutt, N., Pavlakis, N., et al (2018). Adjuvant therapy for resected colon cancer 2017, including the IDEA analysis. Expert Review of Anticancer Therapy, 18(4), 339-349. [More Information]
  • Shapiro, J., Thavaneswaran, S., Underhill, C., Robledo, K., Karapetis, C., Day, F., Nott, L., Jefford, M., Chantrill, L., Pavlakis, N., Khasraw, M., Simes, R., Gebski, V., et al (2018). Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study. Clinical Colorectal Cancer, 17(4), 313-319. [More Information]
  • Chan, D., Moody, L., Segelov, E., Metz, D., Strosberg, J., Pavlakis, N., Singh, S. (2018). Follow-Up for Resected Gastroenteropancreatic Neuroendocrine Tumours: A Practice Survey of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETS) and the North American Neuroendocrine Tumor Society (NANETS). Neuroendocrinology, 107(1), 32-41. [More Information]
  • Singh, S., Moody, L., Chan, D., Metz, D., Strosberg, J., Asmis, T., Bailey, D., Bergsland, E., Pavlakis, N., Segelov, E., et al (2018). Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors. JAMA Oncology, 4(11), 1597-1604. [More Information]
  • Price, T., Tang, M., Gibbs, P., Haller, D., Peeters, M., Arnold, D., Segelov, E., Roy, A., Tebbutt, N., Pavlakis, N., et al (2018). Targeted therapy for metastatic colorectal cancer. Expert Review of Anticancer Therapy, 18(10), 991-1006. [More Information]

2017

  • Sandler, C., Goldstein, D., Horsfield, S., Bennett, B., Friedlander, M., Bastick, P., Lewis, C., Segelov, E., Boyle, F., Chin, M., et al (2017). Randomized Evaluation of Cognitive-Behavioral Therapy and Graded Exercise Therapy for Post-Cancer Fatigue. Journal of Pain and Symptom Management, 54(1), 74-84. [More Information]

2014

  • Soon, S., Chia, J., Chan, M., Ho, G., Jian, X., Deng, Y., Tan, C., Segelov, E., Mehta, S., Ali, R., et al (2014). Cost-Effectiveness of Aspirin Adjuvant Therapy in Early Stage Colorectal Cancer in Older Patients. PloS One, 9(9), 1-14. [More Information]

2012

  • Price, T., Shapiro, J., Segelov, E., Karapetis, C., Pavlakis, N., Van Cutsem, E., Shah, M., Kang, Y., Tebbutt, N. (2012). Management of advanced gastric cancer. Expert Review of Gastroenterology and Hepatology, 6(2), 199-209. [More Information]

2010

  • Tebbutt, N., Karapetis, C., Segelov, E., Pavlakis, N., Cunningham, D., Sobrero, A., Haller, D., Shapiro, J. (2010). Current Opinion on Optimal Treatment Choices in First-line Therapy for Advanced or Metastatic Colorectal Cancer: Report From the Adelaide Colorectal Tumour Group Meeting; Stockholm, Sweden; September 2008. Clinical Colorectal Cancer, 9(1), 8-14. [More Information]

To update your profile click here. For support on your academic profile contact .